<DOC>
	<DOCNO>NCT00982501</DOCNO>
	<brief_summary>The purpose study test : 1 . Safety 900 mg 1800 mg WS® 1442 per day overweight subject ( BMI 25 29,9 kg/m² ) 2 . Pharmacodynamic effect WS® 1442 endothelial function versus nordic walk train overweight subject</brief_summary>
	<brief_title>WS®1442 Slightly Overweight Subjects</brief_title>
	<detailed_description>60 overweight subject BMI 25 29,9 kg/m2 include . The safety 900 mg/1800 mg per day WS® 1442 determine adverse event , laboratory parameter , vital sign well treadmill test begin end study . Endothelial function measure two different train modality compare measured intake two different dos WS® 1442 .</detailed_description>
	<mesh_term>Overweight</mesh_term>
	<criteria>write informed consent male female subject age 4575 year untrained BMI 25 29,9 kg/m² rest blood pressure sit position ≤ 140/90 mmHg inconspicuous ergometry pregnancy breastfeed current medication intake hawthorn preparation dietary supplement possible influence interpretation study result know disease alcohol drug abuse/addiction nicotine abuse know hypersensitivity ingredient investigate drug inability inadequate ability write speak German notpostmenopausal woman : positive pregnancy test unsafe contraception urinary test find require diagnostic assessment treatment deformation 2nd 5th finger hand prevent adequate measurement endothelial function</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>( BMI 25-29,9 kg/m2 )</keyword>
</DOC>